INNOVATION IN RESPIRATORY
DIFFERENTIATED GENERIC MEDICINES THAT MEET RESPIRATORY NEEDS
There is no cure for asthma or COPD. Yet effective treatments can help to control the symptoms and allow for a fuller, more active life. Sandoz’ growing portfolio of innovative respiratory medicines shows our commitment to high-value products that provide patients with affordable, quality treatment options.
Our differentiated products are designed with patients in order to improve the treatment experience. For example, the design of AirFluSal® Forspiro® benefitted greatly from patient input. The multi-dose dry powder inhaler features a clear and accurate dose counter1, as well as a simple lever arm for loading the dose and visual control features for additional reassurance about dosing.
In 2011, the intuitive design of the AirFluSal® Forspiro® inhaler earned the Red Dot Product Design award, an internationally recognized quality seal of approval from the Design Zentrum Nordrhein Westfalen in Essen, Germany.
Developing such new products underscores Sandoz’ commitment in focusing on differentiated products in therapeutic areas where we see the greatest need.
1 S. Jones, T. Weuthen, Q.J. Harmer, J.C. Virchow. P7, Assessing the intuitive ease of use of a novel dry powder inhaler, the Forspiro® device, for asthma and COPD. Thorax 2012; 67: A66−A67; doi:10.1136/thoraxjnl-2012-202678.148.